Steven S. Raman, MD

David Geffin School of Medicine, University of California, Los Angeles

Los Angeles, California

Steven S. Raman, MD, is Clinical Professor of Radiology and Director of Prostate MR Imaging and Interventions at the David Geffen School of Medicine of the University of California, Los Angeles (UCLA). Dr. Raman is an expert in abdominal and pelvic imaging (CT, MRI, US, and X-Ray) and interventional radiology (image-guided procedures), especially in the area of tumor ablation and fibroid treatment. He is Director of the Abdominal Imaging Fellowship and Co-Director of the Fibroid Treatment Program, both at UCLA. Dr. Raman received his MD from the Keck School of Medicine at the University of Southern California, and then completed a fellowship in Radiological Sciences at the University of California, San Diego, as well as a residency in Radiological Sciences at UCLA. He is board-certified in diagnostic radiology.

Disclosures:

Talks by Steven S. Raman, MD

Integration of Histology, Genomics and Proteomics with MRI

Posted by Steven S. Raman, MD | Aug 2024

Steven S. Raman, MD, explores how histology, genomics, and proteomics with MRI revolutionize the diagnosis and treatment of prostate cancer. Histology provides critical insights into the pathological features of prostate cancer; genomics offers a deeper understanding of the genetic mutations and alterations that drive cancer progression; and proteomics sheds light on the protein expressions and interactions that occur within the tumor microenvironment. Raman asserts that each modality, while powerful on its own, gains significance when integrated with MRI prostate imaging.

He elaborates on the technological advancements and methodological innovations that facilitate this integration. Raman highlights how multi-parametric MRI (mpMRI) can be augmented with molecular data from histology, genomics, and proteomics to create a more comprehensive and nuanced diagnostic picture. Recent studies show significant improvements in the detection, characterization, and monitoring of prostate cancer, leading to more personalized and effective treatment strategies.

Image-Guided Minimally-Invasive Whole Gland Treatment

Posted by Steven S. Raman, MD | Mar 2021

Steven S. Raman, MD, Clinical Professor of Radiology and Director of Prostate MR Imaging and Interventions at the David Geffen School of Medicine of the University of California, Los Angeles, explains how magnetic resonance imaging (MRI) aids in prostate cancer staging, diagnosis, follow-up, treatment planning, and image-guided treatment. After reviewing relevant FDA guidelines, Dr. Raman outlines the MRI-guided transurethral ultrasound ablation (TULSA)-PRO® treatment planning and delivery process, noting the potential for real-time MR thermometry and feedback control. To further display benefits of the treatment, he reviews outcomes from the TACT trial. He then addresses potential next steps in prostate tissue ablation.